News

Clarissa Desjardins, CEO of Congruence Therapeutics, met Mr. Bellini 30 years ago as a young life sciences entrepreneur. In ...
The Philadelphia gene therapy company said the cuts were "part of a broader effort to right size the organization." ...
For the third time in four years, CNBC has ranked North Carolina as “America’s Top State for Business” in 2025.
Charles E. Hamner Jr., a highly respected and accomplished scientist, university administrator and pharmaceutical executive who led the North Carolina Biotechnology Center during its formative years, ...
Dr. Singh took a pragmatic view of the booming biotech startup sector, which has grown from 50 startups in 2014 to over 11,000 today.
The opportunities I had as an aspiring researcher are gone. The path to a better life for kids in Sacramento is slipping away ...
Catalent Pharma Solutions' latest expansion in Madison is bringing a boost to Wisconsin’s growing biohealth sector, with a ...
Is the day of the zombie biotech coming to an end? Eyes have it: Peninsula biotech focuses on glaucoma, more in big test Eyes have it: Peninsula biotech focuses on glaucoma, more in big test © 2025 ...
Notice of the Cambridge biotech's layoffs came less than two weeks after Sage announced it would be acquired by ...